The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests

The C-Terminal Half of SARS-CoV-2 Nucleocapsid Protein, Industrially Produced in Plants, Is Valid as Antigen in COVID-19 Serological Tests

BackgroundThe fight against the current coronavirus disease 2019 (COVID-19) pandemic has created a huge demand of biotechnological, pharmaceutical, research and sanitary materials at unprecedented scales. One of the most urgent demands affects the diagnostic tests. The growing need for rapid and acc...

Full description

Bibliographic Details
Main Authors: Laura Williams, Silvia Jurado, Francisco Llorente, Alberto Romualdo, Sara González, Ana Saconne, Isabel Bronchalo, Mercedes Martínez-Cortes, Beatriz Pérez-Gómez, Fernando Ponz, Miguel Ángel Jiménez-Clavero, Pablo Lunello
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Plant Science
Subjects:
COVID-19
SARS CoV-2 nucleocapsid protein
biofactories
plant expression
molecular farming
ELISA coronavirus
Online Access:https://www.frontiersin.org/articles/10.3389/fpls.2021.699665/full

Internet

https://www.frontiersin.org/articles/10.3389/fpls.2021.699665/full

Similar Items